Re: radiopharmaceutical patient release

["J. J. Rozental" <josrozen@netmedia.net.il>]

At 07:08 AM 2/8/97 -0600, you wrote:
>Mr Rozental
>
>Please give a full, or accurate, citation of your references. Otherwise, it
>can be difficult to find them. Thank you.
>
>Chris Alston
>ccja@aol.com
>
>
>
Thank you for your request

REFERENCE:

1 - International Commission on Radiological Protection no.26, 1977
The three basic statement for the system of dose limitation were  instituted
in this document                                         

2 - Introduction to Health Physics
by Herman Cember, Pergamon Press
He is professor at Northwestern University, Technological Institute,
Evaston, Illinois

3 - Radiation Protection, A Guide for Scientists and Physicians
by Jacob Shapiro, Harvard University Press

4 -INTERNATIONAL RADIATION PROTECTION ASSOCIATION - IRPA
proceedings of the last IRPA 9 - 1966 International Congress on Radiation
Protection held in Vienna April 14-19,

a) Effective Dose and Effective Dose Equivalent in nuclear medicine
R. E. Toohney and G. Stabin -  Vol. 3, page 473/475, Oak Ridge Institute for
Science and Education, Oak Ridge

b - Development of Mathematical Phantoms for calculating internal doses from
radiopharmaceuticals using patients' digital picture of bone scintillation,
Vol. 3, page 479
K. Akahane(1) , M. Kai (2) T. Kusama (2) 
(1) The Institute of Public Heath, Tokyo, Japan
(2) The University of Tokyo, Tokio, Japan

c - Radiation dose rates from patients undergoing Gallium-67 Citrate study
K. Ejiri (1), S. Koga, T. Orito (1), H. Ohse (3), T. Nishimura (3), K.
Yokoyama (3) and H. Toyama (2), Vol. 3, page 547/549
(1) Faculty of Radiological Technology, Fujita Health University School of
Health Sciences
(2) Departament of Radiology, Fujita Health University, School of Medicine,
(3) Fujita Health University Hospital, Toyoake, Japan.

d - Radiation Exposure around patients after administration of Tc-99m-DPD or
Tl-201-Chloride, Vol. 3, page 550/552
Ernst Havlik (1), A. Kurtaran (2), J. Preifellner (2)
(1) Dept. of Biomedical Engineering and Physics, Univ. of Vienna and 
L. Boltzmann-Institute of Nuclear Medicine, Vienna,
(2) Dept. of Nuclear Medicine, Univ. Clinic, Vienna

e - Development of Thyroid monitoring system for radiodine in Thyroid Gland,
Vol. 2, page 498
Hideky Hangai and Seiichi Mizushita,  Japan Atomic Energy Research Institute,
Tokai-mura, Naka-gun, Ibaraki-ken, Japan

Please find all information about that Congress   and many others' on
Radiation Protection at
http://www.tue.nl/sbd/irpa/irpahome.htma

J. J. Rozental <josrozen@netmedia.net.il>
Consultant, Radiatio Safety & Regulation
for developing country